GET THE APP

Biofilm Configuration and Applications
..

Veterinary Science & Technology

ISSN: 2157-7579

Open Access

Editorial - (2022) Volume 13, Issue 4

Biofilm Configuration and Applications

Anmaw Abat*
*Correspondence: Anmaw Abat, Department of Veterinary Medicine, University of Gondar, Gondar, Ethiopia, Tel: 9238506894, Email:
Department of Veterinary Medicine, University of Gondar, Gondar, Ethiopia

Received: 02-Apr-2022, Manuscript No. jvst-22-69797; Editor assigned: 04-Apr-2022, Pre QC No. P-69797; Reviewed: 09-Apr-2022, QC No. Q-69797; Revised: 14-Apr-2022, Manuscript No. R-69797; Published: 19-Apr-2022 , DOI: 10.37421/2157-7579.2022.13.121
Citation: Abat, Anmaw. “Biofilm Configuration and Applications.” J Vet Sci Techno 13 (2022): 121.
Copyright: © 2022 Abat A. This is an open-access article distributed under the terms of the creative commons attribution license which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Editorial

Biofilms can be formed on both biotic and abiotic surfaces, including on living tissues, indwelling medical devices, industrial or portable water system piping, and natural aquatic systems. It has been estimated that biofilms account for over 80% of the chronic and recurrent microbial infections in humans. Biofilms are composed of microorganisms embedded in a self-produced extracellular matrix (ECM) composed of extracellular polymeric substances (EPS) such as polysaccharides, proteins, nucleic acids (e-DNA and e-RNA), lipids, and other biomolecules. EPS accounts for 50%–90% of the total organic carbon of biofilms [1]. In addition to the above components, water (up to 97%) is a major part of biofilm and facilitates the flow of nutrients inside the biofilm matrix. The composition and structure of biofilms can vary depending on the type of microorganism, the host environment, the availability of nutrients, shear stress, etc. Noncellular materials such as corrosion particles, mineral crystals, clay or slit particles, or blood components may be found in the biofilm matrix depending on the type of environment in which the biofilm has formed. These medical devices commonly contain pure culture biofilms. However, water system biofilms are highly complex and contain filamentous bacteria, freshwater diatoms, clay material, corrosion products, etc. [2].

EPS components are vital to providing structural and functional attributes to the biofilm, which can be generally classified into physical and chemical properties. The biofilms of Gram-negative bacteria contain polysaccharides that are neutral or polyanionic due to the presence of uronic acids or ketallinked pyruvates, which provides a greater binding force in a developed biofilm. In the case of Gram-positive bacteria, the chemical composition of EPS is primarily cationic. The primary conformation of the biofilm is determined by the composition and structure of the polysaccharides. Many of the bacterial EPS that contain 1,3- or 1,4-β-linked hexose residues tend to be more rigid, less deformable, and poorly soluble or insoluble. Generally, EPS may be hydrophobic, although it can be both hydrophilic and hydrophobic. Since EPS is highly hydrated, it helps to prevent desiccation in some natural biofilms [3].Additionally, EPS may contribute to antimicrobial resistance by facilitating the mass transport of antibiotics through the biofilm, mostly by directly binding to these agents. EPS is not generally uniform, and different organisms produce varying amounts of EPS. The minerals serve as an essential component of the EPS and support the morphogenesis of bacterial colonies. In some cases, it also provides structural integrity to the biofilm matrix and acts as a scaffold that protects the bacterial cells from shear forces and antimicrobial agents. EPS also promotes cell adhesion to solid substrates and cohesion among bacterial cells that are important for biofilm formation. In addition to providing protection against antimicrobials, EPS also offers physical stability and resistance to mechanical removal. The viscoelasticity of mature biofilms makes them difficult to remove, even under high mechanical pressure and sustained fluid shear stress [4].

Though biofilms are often considered to be destructive in the clinical and industrial fields, many biofilms are potentially beneficial. Recently, biofilms have been intentionally engineered for various applications in food, agriculture, medicine, the environment, and other fields.

Bacterial biofilms on the surfaces of leaves, roots, and stems act as biocontrol agents that protect the plants from soil-borne pathogens. In addition, beneficial biofilm-forming bacteria have the potential to be employed as biofertilizers, as they can promote plant growth through nitrogen fixation, phytohormone production, disease suppression, etc. For example, Bacillus subtilis is a prominent rhizobacterium and is an efficient biocontrol agent and growth-promotion agent due to its ability to form robust biofilms and to synthesize several antagonistic metabolites, including lipopeptides, bacteriocins, and siderophores. The lipopeptide known as sulfactin protects plants from Pseudomonas syringae infection.

Currently, there is increasing interest in the use of biofilm-forming microorganisms as bioremediation agents, as they convert hazardous environmental substances into less toxic or harmless compounds. The microorganisms living in biofilms display the highest tolerance to contaminants as well as increased survival and adaptation to toxic environments compared to their planktonic counterparts. The bacteria that can remediate environmental pollutants include Pseudomonas, Rhodococcus, Burkholderia, Dehalococcides, Arthrobacter, Bacillus, Alcanivorax, and Cycloclasticus [5].

Conflict of Interest

None.

References

  1. Hall-Stoodley, Luanne, J. William Costerton, and Paul Stoodley. "Bacterial biofilms: from the natural environment to infectious diseases." Nat Rev Microbiol 2 (2004): 95-108.
  2. Google Scholar, Crossref, Indexed at

  3. Davies, David. "Understanding biofilm resistance to antibacterial agents." Nat Rev Drug Discovery 2 (2003): 114-122.
  4. Google Scholar, Crossref, Indexed at

  5. Flemming, H. C and J. Wingender. "The biofilm matrix." Microbiol (2010): 623-633.
  6. Google Scholar, Crossref, Indexed at

  7. Evans, Leonard Vernon. “Biofilms: recent advances in their study and control.” CRC Press 2000 (2000): pp. 19â??34.
  8. Lu, Timothy K and James J. Collins. "Dispersing biofilms with engineered enzymatic bacteriophage." Proceedings of the National Academy of Sciences 27 (2007): 11197-11202.
  9. Google Scholar, Crossref

Google Scholar citation report
Citations: 4472

Veterinary Science & Technology received 4472 citations as per Google Scholar report

Veterinary Science & Technology peer review process verified at publons

Indexed In

arrow_upward arrow_upward